Try our Advanced Search for more refined results
Life Sciences - September, 2023
336 articles
- US Chamber Loses Bid To Stop Medicare Drug Price Talks
- Gilead Must Face HIV Drug Design-Defect Claims At Trial
- 'Prescription Diet' Pet Food Buyers Win Cert. In Fraud Suit
- FDA Wants Oversight Of Lab-Developed Tests
- Ex-USPTO Head Says Breaking Patents Won't Cut Drug Prices
- Generic Cos. Must Face IP Claims Over Novartis Blockbuster
- Pro Say: A Cheat Sheet For The New Supreme Court Term
- States Ask To Block Sandoz Spinoff Over Price-Fixing Claims
- HHS Watchdog Says Pathology Deal Carries Kickback Risk
- Atty Files FOIA Suit Over HHS Pot Recommendation Letter
- Hospice Head Gets 4 Years For $150M Medicare Billing Fraud
- Avoiding The Ethical Pitfalls Of Crowdfunded Legal Fees
- O'Melveny Steers Cancer-Focused Biotech Firm's $58M IPO
- 'False' Info Led To Pfizer Insider Trading Case, Court Told
- Texas Firm Tells Appeals Court Anti-SLAPP Move Is Stall Effort
- 'Administrative State' Attacks Soar To High Court Crescendo
- Kirkland-Led Cinven Paying $1.3B In Synlab Buyout
- UK Litigation Roundup: Here's What You Missed In London
- 4 Pharma Industry Arguments Against CMS Drug Pricing Plan
- Mich. Judge Trims Contract Breach Suit Against R&B Singer
- First-Time Advocates Dominate High Court's Fall Schedule
- Taxation With Representation: Skadden, Ropes & Gray
- 5 Supreme Court Cases To Watch This Fall
- Fed. Circ. Forecast: Intel Looks To Sink $2B Patent Loss
- Opioid Special Master's Email Doesn't Betray Bias, Court Told
- SEC's 'Shadow Trading' Test Case Fails Miserably, Court Told
- Boehringer Bemoans Medicare Drug Price Talks As 'A Sham'
- Regeneron Wins Higher Bar At Trial For FCA Kickback Theory
- Texas Appeals Court Upholds Temporary Block Of Delta-8 Ban
- Watchdog Questions Competition In $45M KPMG COVID Deal
- Fed. Circ. Won't Revive Masimo Medical Alarm IP
- Imerys Insurers Will Get Mediator For Ch. 11 Settlement Effort
- MSN Beats Allergan's Generic Patent Row In Bench Trial
- As AI Pricing Tools Evolve, So Does Antitrust Risk
- Monsanto Wins Directed Verdict In Missouri Roundup Trial
- Bradley Arant Accused Of 'Double-Talk' Over Deposition Texts
- Eastman Chemical To Sell Texas City Operations For $490M
- Issues Ahead As Psychedelic Medicine Faces Pivotal Moment
- Ohio Justices Query State's Bid To Lift Block On Abortion Ban
- Monsanto Questions Relevance Of PCB Rat Research At Trial
- Roundup Plaintiff Rests Case In Mo.
- Sutter Health Nears Win In Physician's Suit Alleging Kickbacks
- SEC Doles Out $1.5M In Fines Over Insider Reporting Failures
- Noteholders, Shareholders Call Mallinckrodt Ch. 11 Plan Unfair
- Implant Co. Loses Appeal On FCA Misbranding Question
- Mylan Dodges Contract Breach Claim In Takeda IP Fight
- Takeda Unit, Ex-Worker Resolve Bias And Retaliation Suit
- AstraZeneca Seeks Quick Win In Drug Price Negotiation Fight
- 7th Circ. Judge Unsure X-Ray Tech Was Fired For Complaint
- Avalyn Pharma Raises $175M In Series C Financing Round
- EPA IG Wants Better Oversight Of Great Lakes Grant Program
- Biotech Biz Evozyne Closes $81M Series B Funding Round
- Surgalign Gets Texas Judge's OK For Ch. 11 Plan
- Virgin Pulse To Merge With HealthComp In $3B Deal
- 3rd Circ. Won't Revive Malpractice Suit Against Polsinelli
- Bracing For Regulatory Delays As Shutdown Looms
- Mintz Bolsters IP And Finance Benches With 2 New Partners
- An Overview Of 6 PBM Bills Moving Through Congress
- McKinsey Strikes $230M Opioid Deal With Gov'ts And Schools
- Monsanto PCBs Didn't Show Up In Testing, Seattle Jury Told
- Eli Lilly Gets $177M Teva Migraine Drug Patent Verdict Tossed
- Eyelid Wiper New Enough To Judge To Keep Patent Suit Alive
- Food 'Fraud' Can't Apply To Nursing Homes, NJ Justices Told
- Axsome Beats Securities Suit Over Migraine Drug, For Now
- Hospital Freed From Mo. Man's Suit Over Wife's Sperm Swap
- Anti-Fraud Group Defends FCA's Whistleblower Provisions
- Amazon, Google Give Views On Counterfeit Goods
- Commerce Stands Firm On Japanese Glycine Levies
- Judge Limits Flint Expert's Testimony On 'Community Trauma'
- Doctors Back 5th Circ. Bid To Nix 'No Surprises' Billing Reg
- Enviro Groups Urge EPA To Regulate Rail Cars' Coal Pollution
- Sutter Health Bills Included Unnecessary Charges, Judge Told
- 3 Firms Build Alfasigma's Nearly $800M Intercept Pharma Buy
- Astellas Sued In Del. Over Millions In Drug Milestone Payouts
- Judge OKs Fees For Talc Lawyers In J&J Unit's First Ch. 11
- Vanda Challenges FDA's Clearance Of Generic Sleep Drug
- Exclusivity Loss Holds Power In Trade Secret Damages Claims
- Florida Man Admits To $16.7M HIV Drug Fraud Conspiracy
- The 2023 Law360 Pulse Social Impact Leaders
- Why Law Firm ESG Is Likely Here To Stay
- What Large Language Models Mean For Document Review
- Proskauer, VC Settle Over Alleged $636M Copy-Paste Error
- Corning Prevails In Long-Running Fight Over Cell-Culture IP
- Monsanto's 1971 PCB Study Had Fake Data, Seattle Jury Told
- PBM Group Must Respond To 10th Circ. En Banc Petition
- IBM, J&J Face Class Action Over August Patient Data Breach
- Sutter Health Judge Doubts Plaintiff's Expert In $519M Trial
- NC Abortion Law 'Irrational,' Federal Court Hears
- Target Must Face Bulk Of Suit Over 'Non-Drowsy' Flu Medicine
- Checking In On How SuperValu Has Altered FCA Litigation
- Catching Up With Delaware's Chancery Court
- PharMerica Unit Hit With Data Breach Class Action In Calif.
- Reed Smith VC Chair Joins Dentons' Tech Practice In Calif.
- Class Seeks $1.1M Atty Fees In CVS Lidocaine Label Suit
- Future Paths For AI Inventorship After Justices' Thaler Denial
- Participating In Living History Makes Me A Better Lawyer
- How Attys Can Weather The Next Disaster Litigation Crisis
- Roundup User Tells Jury Agriculture Jobs Didn't Cause Cancer
- Philly PD's Win In Miscarriage Suit Tossed Over Pot Reference
- ITC Reverses Brita's Water Filter Patent Win
- Drug Co. Again Seeks Toss Of $950M Vax Trade Secrets Case
- Too Many Patents Are Going To Large Cos., Economists Say
- Judge Slightly Pares Down Eye Software Trade Secrets Suit
- Patent Office Has Authority Over Petitions, Court Told
- Sandoz Can't Get New Trial After $39M Eyelash Serum IP Loss
- No COVID Coverage For Entertainment Co., Calif. Panel Says
- Mich. Panel Says Oncology Co. Owes Taxes On Lab Supplies
- Eastern District Of Mich. Judge To Take Inactive Status
- Estate Wants Full 10th Circ. To Review EMT Liability Claims
- Private Equity Owners Can Remedy Law Firms' Agency Issues
- ATS Corp. Buys Water Purification Equipment Co. For $195M
- Application Of Defend Trade Secrets Act Continues To Vary
- UK Litigation Roundup: Here's What You Missed In London
- Firm Fights Sanctions In Georgia-Pacific Unit's Bankruptcy
- Calif. Sues 'Predatory' Clinics Over 'Abortion Pill Reversal'
- Pomerantz To Be Lead Counsel In Mallinckrodt Investor Suit
- Gilead Sciences Gets Initial OK On $247M HIV Antitrust Deal
- Monsanto Funded Favorable Roundup Research, Jury Told
- Judge Tosses Suit Claiming Lead In Vitamin Shoppe Products
- Opioid MDL Special Master Fights Bias DQ For 'Email Mistake'
- La. Sued Again Over Changes To US Drug Discount Program
- Canadian Tribe Denied More Time To Appeal Purdue Injunction
- Yale, Prof. To Pay $1.5M And Share Drug Royalties In FCA Deal
- Drug Cabinet Finger Scans Are BIPA-Exempt, Ill. Justices Hear
- Pa. Nonprofit Says Ex-CFO's Whistleblower Suit Lacks NJ Ties
- Abbott Gets Partial Win In HIV Test Patent Feud With Novartis
- A Topic-Based Analysis Of FDA Responses To FOIA Requests
- Proving Causation Is Key To Fairness And Justice
- Fla. Nurse Convicted In $200M Medicare False Billing Scheme
- FTC Accuses PE Firm Of Raising Anesthesia Prices In Texas
- Skadden Nabs $19M Fee For 4 Months' Work On Endo Ch. 11
- Nelson Mullins Adds Dechert Trial Atty/Doctor In San Diego
- Fed. Circ. Affirms PTAB Ax Of Radiation Therapy Patent
- Arnold & Porter Adds Former Intel Corp. Atty in Washington
- Bradley Arant Fights Sanctions Bid Over Mid-Deposition Texts
- Feds Nab Plea Over Inside Info Stolen From BigLaw Associate
- Deals Rumor Mill: Disney, Mallinckrodt, XFL-USFL
- Tenn. AG Inks $44.5M Opioid Deal With Grocery Chain
- $10M Verdict Against Intuitive Lowered To Just A Dollar
- Supplement Co. Wants McCarter & English Win Slashed
- Sutter Health Owes $519M For Double-Billing, Trial Judge Told
- Stryker Appeals OsteoMed's Surgical Implant Patent Wins
- Mallinckrodt Gets Final OK For $250M Ch. 11 Financing
- Drug Cos. Don't Always Provide Required Discounts To Gov't
- House Bill Would Shield Psilocybin Legalization From DOJ
- Ill. Justices Mull Sending Suit Over Abbott Drug To Jury
- Biden Admin Extends Comment Period On Mental Health Regs
- Del. Justices Urged To Reverse AmerisourceBergen Dismissal
- NJ Judge Tosses Proposed Cannabis REIT Investor Suit
- Opiate MDL Special Master Faces DQ Bid Over 'Reply All' Goof
- Fed. Circ. Hands Win To Roche In Blood Drug Fight
- How To Protect Atty-Client Privilege While Using Generative AI
- Takeda Settles Gout Drug Antitrust Case Midtrial
- Orrick Adds MoFo Tech And Life Sciences IP Litigator In SF
- Arnold & Porter Opens Boston Office With Life Science Focus
- Humana Tries To Ax Walgreens' Claims Over Crowell & Moring
- Eli Lilly Launches 10 Suits Over New Diabetes Drug
- Merck Chided By AARP, Democrats Over Drug Price Suit
- New Jersey Shore Town Wants Pot Co.'s Zoning Suit Tossed
- Judge OKs Juul's $255M Deal, Bars AI Co.'s 'En Masse' Claims
- J&J Defends Texas Two-Step Talc Gambit To Lawmakers
- Texas Atty Blamed 'Brain Fart' For False Statement, SEC Says
- 1st Circ. Sides With J&J Subsidiary In Lactaid False Ad Suit
- Takeda Wants End To Gout Drug Antitrust Case Midtrial
- HIV Drug Case Against Gilead Threatens Medical Innovation
- Two Del. Suits Seek Info On $462M Paratek Deal's Losing Bids
- Valeant Says 9th Circ.'s FCA Disclosure Ruling Went Too Far
- How New Lawyers Can Leverage Feedback For Growth
- Doc Becomes 3rd Of 5 In Alexion Insider Case To Admit Guilt
- Regeneron Partly Agrees It Infringed COVID Tech Patent
- Maine Hospitals Urge High Court To Deny Review Of Vax Suit
- COVID Test Maker Lucira Gets OK For Ch. 11 Liquidation
- Boston Scientific To Buy MedTech Biz In $850M Cash Deal
- RICO Trade Secret Standard Prevails Within 9th Circ. Courts
- 2 Firms Help Swedish Drug Co. Sobi Raise $540M
- Walgreens Slams Crowell 'Hail Mary' To Avoid Ethics Hearing
- Inventor Tells Justices Amgen Ruling Dooms Alice
- Roundup's Cancer Link Has Solidified Over Time, Jury Hears
- FDA Warns Vape Cos. To Stop Selling 'Illegal' Products
- UK Antitrust Court Upholds £130M In Allergan Fines
- Mylan Hit With Patent Suit Over Generic Nausea Drug
- Target And P&G Sued Over 'Useless' Nasal Decongestant
- Catching Up With Delaware's Chancery Court
- MLB Stars Drop Al Jazeera Defamation Suits Over Doping Doc
- Sanofi Slams Mylan's 'Mishmash' Of Claims Over Insulin
- ESG Around The World: Australia
- Vedder Price Adds Ex-Nixon Peabody Litigator In Chicago
- Concerns For 510(k) Sponsors After FDA Proposes Major Shift
- High Court's New FCA Ruling Is Quickly Making Trials Likelier
- University Of Calif., MIT Top List Of Schools Getting Patents
- Teva Faces Massive Investor Suit Over Opioid Scandal Fallout
- Louisiana Lab Owner Gets 3 Years For Medicare Kickback Ploy
- Chamber Urges Court To Block Medicare Drug Price Program
- Justices Urged To Restore Suit Targeting PTAB's Fintiv Rule
- Biotech Firms Join IPO Wave After Raising $561M Combined
- GSK, P&G And Others Sued Over 'Ineffective Decongestants'
- Developers Are Testing Defenses In Generative AI Litigation
- Approval Regs Must Change To Keep Up With Biologics Tech
- Ex-Alexion Vice President Admits To Insider Trading Charges
- Address The Data Monopoly, Otherwise Tech Giants Control AI
- Minn. Product Case Highlights Challenges Of Misuse Defense
- UK Litigation Roundup: Here's What You Missed In London
- Novartis Shareholders OK Spinoff Of $9.6B Sandoz Unit
- Vaccine Maker Beats Investor Suit Over Private Investment
- Amyris Fails To Get Final OK On $190M DIP Loan
- P&G And J&J Sold Useless Decongestants, Suit Says
- 10x Beats Rival's Bid To Ax Genetics Patents As Ineligible
- Arm's Blockbuster IPO Likely To Clear Path For More Offerings
- Vyera Floats Rights Offering To Fix Ch. 11 Plan Objections
- Meta Must Face DC's COVID Vaccine Misinformation Subpoena
- Fed. Circ. Won't Touch Hypertension Drug Producer's Loss
- High Court's ID Theft Limits No Help To Drug Rep, Judge Says
- Pfizer, BioNTech Lob Counterclaims In MRNA Vax Tech Suit
- FTC Warns Drugmakers Against Listing Illegitimate Patents
- Abcam Founder Opposes Danaher Deal, Wants Board Gone
- Myovant, Sumitomo Deal Hurt By Skadden Conflict, Suit Says
- Biopharm Firm Hit With 2nd Suit Alleging Unpaid Wages
- Ex-Pfizer Worker To Stand Trial In Paxlovid Insider Case
- The Impact Of A Del. District's Procedural Shift On Disclosures
- Twitter Legal Fees Suit Offers Crash Course In Billing Ethics
- Product Liability Claims Rose Over 5 Years, Report Says
- Roundup Agricultural Use Irrelevant To Cancer Suit, Jury Told
- Alexion Inks $125M Deal In Investors' Suit Over Sales Tactics
- Medicaid Agency's Immunity From Retaliation Claim Affirmed
- Old Offer To Drop Chancery Case Roils Bioverativ Settlement
- Cardinal Health, Investors Get Final OK For $109M Settlement
- AbbVie Asks Court To Compel IRS Docs For $1.6B Dispute
- Medical Device Cos. Fight To Toss Conn. Birth Control Suits
- Leveraging The Strategic Pause In Patent Prosecution
- EU Privacy Framework Bodes Well For US Life Sciences Cos.
- Shkreli-Tied Pharma Co. Cleared For $650K Ch. 11 Sale
- Laws Based On Rapid Drug Tests Are Unscientific And Unfair
- Amgen-Horizon Deal May Signal FTC's Return To Bargaining
- Integra Downplayed FDA Factory Warnings, Investor Suit Says
- Calif. Lawmakers Pass Pioneering Carbon Disclosure Bill
- Sorrento OK'd For Alternative $110M Ch. 11 Stock Sale
- Insurers Seek Toss Of Foam Co.'s Chemical Coverage Suit
- HHS Assails Merck's 'Misunderstandings' Of Drug Pricing Law
- Organizations Urge Texas Courts To Curb 'Judge Shopping'
- Women Denied Abortions Launch Complaints In 3 States
- Fed. Circ. Backs Apple's PTAB Wins In Masimo Patent War
- 5th Circ. Presses Illumina On Cancer Test Competition
- Opioid Sales Fell By Half After 2010, DEA Data Shows
- Prisoner, 3 Others Cop To $25M COVID Relief Fraud
- SEC Hits Health Care Co. And Owner With $2.7M Fraud Suit
- BigLaw Associate's Ex Faces January Insider Trading Trial
- Indian Co. Urges Fed. Circ. To Back Obviousness Of Oxy IP
- Amgen Patent Ruling's Impact Extends Beyond Life Sciences
- 6th Circ. Asks Ohio Justices To Settle $650M Opioid Question
- Minn. Catering Biz Owners Cop To $250M Child Meals Scheme
- Latham, Quinn Emanuel Pressed For Docs In Antitrust Case
- InterMune Ex-CEO's Atty Pressed To Defend Legal Fees In Del.
- Pharma Cos. Say Twitter Terror Ruling Requires DC Circ. Redo
- 9th Circ. Judges Open To Reviving Ariz. Abortion Law Fight
- HCA Healthcare Sued In Fla. Over Data Breach Of 11M Patients
- Nitrous Distributor Hit With $700M Verdict Over Crash Death
- Justices Told Ax Of Vitamin Patent Creates Fed. Circ. Split
- Catching Up With Delaware's Chancery Court
- Attys Tout Need For Diverse IP Trial Counsel Amid Skepticism
- ABA's Money-Laundering Resolution Is A Balancing Act
- 8 Ways Life Sciences Cos. Can Adapt To The Social Media Era
- Pool Supply Co. Investors Say COVID Panic Inflated Sales
- 2 Biotech Firms Hope To Tap Thawing IPO Market For $495M
- Doctor Wants J&J Unit's Libel Suit Over Talc Study Tossed
- What Is The Proper Breadth Of An IPR Reply?
- NJ Lab Says Alliant Owes Payment For COVID-19 Testing
- Feds Fight Texas Atty's Bid To Toss Kickback Conviction
- J&J Talc Unit Questions Distress Need In Ch. 11 Appeal
- Fla. Justices Question Abortion's Inclusion In Privacy Right
- Biotech Firm Accused Of 'Gaslighting' In $41M Share Award Suit
- Fed. Circ. Asks What's New About Schizophrenia Drug Patent
- Ex-AstraZeneca Sales Rep Seeks Cert. In Age Bias Action
- HHS Proposes 'Historic' Rule Combating Disability Bias
- PTAB Axes RapidPulse Blood Clot Removal Patent
- Defendant In Harvard Body Theft Case Pleads Guilty
- Recalled Lentil Crumbles Cost Woman Gallbladder, Suit Says
- Fresenius Gets 13 Cases Trimmed From Dialysis MDL
- Justices Urged To Hear Fight Over Abortion Pill Restrictions
- With Equity Markets Down, Venture Lending Provides Solution
- Former Biotech Execs Avoid Prison In Stock Tip Case
- UK Litigation Roundup: Here's What You Missed In London
- Kroger To Pay Up To $1.4B To End Opioid Claims
- Kraft Heinz Must Face Crystal Light False Ad Suit
- Biotech Fired Remote Exec Who Declined Vax, Suit Says
- Rival Gene Sequencing Cos. Must Face November Patent Trial
- Psychedelics Decriminalization Bill Clears Calif. Legislature
- Astellas Drops Suit Over Medicare Drug Price Negotiation Law
- Walgreens Cuts $44M Deal To End Theranos Consumer Suits
- Amyris To Pay Up To $750K In Creditor Group Atty Fees
- Texans Say Claims Court Can't Take Biometrics Fee Suit
- UK Competition Regulator Reviewing Veterinary Industry
- Law Firm Professional Development Steps To Thrive In AI Era
- Consumer Group Backs Ga. Doctor's Appeal In Roundup Suit
- HHS Neuromonitoring Advisory May Have Broad Relevance
- Enhanced Patent Damages: Trends IP Attorneys Should Know
- Attys Vie To Lead Investor Suit Against AI-Based Drugmaker
- Philips Inks $479M Economic Losses Deal In CPAP Recall MDL
- Actelion Ducks RICO Suit Over Hypertension Drugs, For Now
- Altria's $45M Deal With Vapers Over Unsafe E-Cigs Wins OK
- Indoor Farming Co. AppHarvest OK'd For Ch. 11 Asset Sales
- Pomerantz Seeks To Lead Mallinckrodt Investor Suit
- Mass. AG Certifies 2 Psychedelics Legalization Efforts
- FTC-Amgen Deal: 'Major Advance,' Or 'Narrow Assurance'?
- Ga. Judge Pauses Block Of Ban On Trans Youths' Health Care
- Wholesalers Tell Pa. Jury Takeda Delayed Generic Gout Drug
- Ex-Amgen Exec's Startup Settles With Amgen
- 3 Firms Build Up To $600M Sale Of Medical Device Biz
- Uncertain Copyright And Patent Protections In The AI Age
- SmileDirectClub Can't Ax Rival's Bid To Beat Patent Claims
- TM Suit Doesn't Belong In Michigan, Judge Says
- Chancery Upholds AbbVie Damages In Takeda-Lupron Suit
- Veolia Tries To Halt Discovery Into PR Plan In Flint Water Case
- Natera Cancer Test Patents Upheld In Wake Of $19M Verdict
- LA County Says Pharmacy Benefit Cos. Fueled Opioid Crisis
- 'I'm Baffled,' Fed. Circ. Judge Tells Purdue Amid PTAB Appeal
- Emergent Gets Investor Suit Over COVID Vaccine Trimmed
- Chancery Finds Drug Exec Breached Pact With Sorrento
- How Section 101 Claims Can Trigger Invalidity Under Alice
- Potential Marijuana Status Change Would Shift Industry Risks
- Scientist Says Biopharma Firm Withholding Wages
- Investors Say Cannabis Co. Board Hid SEC Investigation
- Unilever Sued Over Injury From Recalled Laundress Product
- Novartis Joins Legal Fray After Price Negotiation List Unveiled
- Hearing Aid Investors Lose 2nd Bid At Suit Over DOJ Probe
- Ga. Asks Court To Rethink Block On State's Trans Health Ban
- NJ Court OKs Cannabis Permits To 'Women-Owned' Cos.
- NC Justices Give Software Maker 2nd Shot At Contract Claims
- Gilead-Backed Stem Cell Startup Beats Patent Suit
- Off The Bench: Sports & Betting Law News You Need To Know
- Biden Pot Reform Effort Puts DEA In Hot Seat
- Trending At The PTAB: Cautionary Tale Of VLSI Challenger
- Atty Tells 9th Circ. Valeant Ruling Saves Allergan Patent Suit
- Mich. Parents Seek $423K Atty Fees, Costs For Infant Data Win
- UK Litigation Roundup: Here's What You Missed In London
- Attys Prepare For IPO Pickup As Market Shows Signs Of Life
- Amgen Gets FTC Green Light On $28B Horizon Deal